Suchergebnisse - "Yao, Jun"

PubPharm (41)

1

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non-small-cell lung cancer who have progressed after anti-PD-1/L1 therapy

enthalten in: Cancer medicine | 2024

von Zhao, Y. | Chen, X. | Yao, J. | +12

2

Dipeniroqueforins A-B and Peniroqueforin D : Eremophilane-Type Sesquiterpenoid Derivatives with Cytotoxic Activity from Penicillium roqueforti

enthalten in: The Journal of organic chemistry | 2024

von Mo, S. | Zhang, Y. | Jiang, R. | +8

3

Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line

enthalten in: Molecules (Basel, Switzerland) | 2022

von Hu, Y. | Yao, J. | Wang, Z. | +6

4

Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Fang, J. | Xu, L. | Shang, L. | +12

5

Recent advances in graphene-based nanomaterials : properties, toxicity and applications in chemistry, biology and medicine

enthalten in: Mikrochimica acta | 2019

von Yao, J. | Wang, H. | Chen, M. | +1

6

Effects of 2-aryl-1-cyano-1,2,3,4-tetrohydroisoquinolines on apoptosis induction mechanism in NB4 and MKN-45 cells

enthalten in: Toxicology in vitro : an international journal published in association with BIBRA | 2019

von Cao, F. | Xu, M. | Zhou, B. | +3

7

Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial

enthalten in: Journal of vascular and interventional radiology : JVIR | 2018

von He, M. | Zou, R. | Wei, W. | +7

8

Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer Prevention

enthalten in: Cancer prevention research (Philadelphia, Pa.) | 2017

von Wang, X. | Yao, J. | Wang, J. | +5

9

Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells

enthalten in: Biochemical pharmacology | 2017

von Sun, W. | Huang, H. | He, B. | +11

10

Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways

enthalten in: Oncology reports | 2016

von Li, G. | He, Y. | Yao, J. | +7

1
2
3
4
5
Nächster »
[5]